Physician profile
Andrew Shimer
NPI 1740274919
$20,686.34
in general payments reported to CMS, 2019-2025
53 companies · $9,150 in 2025
The $9,150 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $765 · 2020: $406 · 2021: $1,285 · 2022: $1,735 · 2023: $1,119 · 2024: $6,227 · 2025: $9,150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $1,862 · Education: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,400.00 |
| Food and Beverage | $1,861.52 |
| Education | $233.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $14,400.00 | 2024-2025 | Bovine Collagen |
| Abbvie INC. | $775.75 | 2019-2024 | Lo Loestrin Fe |
| Intuitive Surgical, INC. | $733.74 | 2022 | |
| Astellas Pharma US INC | $452.46 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $339.49 | 2019-2025 | |
| Organon LLC | $333.03 | 2021-2025 | Nexplanon |
| Gynesonics, INC. | $280.06 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $271.73 | 2020-2021 | |
| Duchesnay USA Incorporated | $230.84 | 2019-2020 | |
| Exeltis, USA INC. | $208.41 | 2020-2025 | Slynd |
| Hologic Sales and Service, LLC | $201.44 | 2019-2025 | Aptima, Thinprep 2000 Processor, Novasure |
| Mayne Pharma Commercial LLC | $182.16 | 2021-2025 | |
| Daiichi Sankyo INC. | $172.10 | 2019-2022 | |
| Myriad Women'S Health, INC. | $150.77 | 2023 | Myrisk |
| Bayer Healthcare Pharmaceuticals INC. | $146.15 | 2019-2024 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $140.46 | 2019-2024 | Intrarosa, Femring |
| Biohaven Pharmaceutical Holding Company LTD. | $116.80 | 2022 | |
| Therapeuticsmd, INC. | $116.31 | 2019-2022 | |
| Agile Therapeutics, INC. | $100.04 | 2022-2024 | Twirla |
| Mylan Pharmaceuticals INC. | $98.05 | 2019-2022 | |
| Aspira Women'S Health INC | $90.50 | 2022 | |
| Allergan, INC. | $81.64 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $76.74 | 2023 | Myfembree |
| Exact Sciences Corporation | $72.34 | 2023-2025 | Cologuard Collection Kit |
| Myovant Sciences INC. | $67.43 | 2021-2022 | |
| Coopersurgical, INC. | $67.34 | 2019-2020 | |
| Scynexis, INC. | $52.75 | 2022 | |
| Evofem Biosciences, INC. | $46.82 | 2021-2025 | Solosec, Phexx, Phexxi |
| Sage Therapeutics, LLC | $45.63 | 2024-2025 | Zurzuvae |
| Abiomed | $43.13 | 2024 | Impella |
| Conmed Corporation | $42.21 | 2025 | Airseal |
| Avanos Medical | $41.24 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $40.54 | 2019-2021 | |
| Axonics, INC. | $40.35 | 2023 | Bulkamid, Axonics |
| Lupin INC. | $40.16 | 2019 | |
| Monaghan Medical Corporation | $40.01 | 2023 | Aeroeclipse |
| Novo Nordisk INC | $39.75 | 2020-2023 | Wegovy |
| Minerva Surgical, INC | $35.55 | 2022-2025 | |
| Medtronic, INC. | $31.78 | 2022-2024 | Ligasure |
| Mission Pharmacal Company | $27.91 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $26.60 | 2019-2021 | |
| Integra Lifesciences Corporation | $25.68 | 2024 | Medihoney, Biodrestore, Biofix |
| Medicem INC. | $23.44 | 2021 | |
| Abbott Laboratories | $20.65 | 2022 | |
| Meditrina | $20.21 | 2023 | |
| Avion Pharmaceuticals | $19.40 | 2019 | |
| Novum Pharma, LLC | $15.78 | 2019 | |
| Sanara Medtech INC. | $13.90 | 2021 | |
| Nalpropion Pharmaceuticals LLC | $13.77 | 2019 | |
| Becton, Dickinson and Company | $12.91 | 2021 | |
| Ethicon US, LLC | $12.30 | 2021 | |
| Channel Medsystems, INC. | $8.09 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Shimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.